Assessment of Trimetazidine Treatment in Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention

Table 6

Repeated laboratory data collected in the hospital.

	TMZ group (n = 145)	Control group (n = 135)	value
CK on day 2 (U/L)	1012 ± 683	1380 ± 1123	0.001
CKMB on day 2 (U/L)	101 ± 65	138 ± 113	0.001
cTNI on day 2 (ng/ml)	18.7 ± 14.6	23.4 ± 18.3	0.018
ALT on day 6 (U/L)	35.3 ± 27.9	48.0 ± 35.9	0.001
AST on day 6 (U/L)	42.8 ± 29.4	67.0 ± 61.5	<0.001
Cr on day 6 (µmo l/L)	77.4 ± 17.2	80.2 ± 24.7	0.267
Urea on day 6 (mmol/L)	6.2 ± 5.3	6.6 ± 14.0	0.742
Glucose on day 6 (mmol/L)	5.9 ± 1.4	6.3 ± 1.5	0.019

All comparisons were two-tailed, and was considered statistically significant.